Mirae Asset Global Investments Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,156 shares of IOVA stock, worth $57,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,156
Previous 10,978
7.49%
Holding current value
$57,279
Previous $103,000
27.18%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IOVA
# of Institutions
319Shares Held
243MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$154 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$150 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$135 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$120 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$74.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $890M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...